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Abstract XCsx2, a homeobox-containing gene, is ex- 
pressed in cardiac muscle during Xenopus development, 
while the XMEF2A gene is expressed in both cardiac and 
skeletal muscle. Microinjection of either XCsx2 or 
XMEF2A mRNA into single blastomeres of two-cell 
stage Xenopus embryos induced precocious expression 
of the myosin heavy-chain alpha (XMHCoO gene at the 
neural plate stage (stage 14). Co-injection of both XCsx2 
and XMEF2A mRNAs induced still earlier expression at 
the late gastrula stage (stage 12). These changes were ev- 
ident in whole embryos but not in animal pole explants 
from injected embryos. Overexpression of XCsx2 or 
XMEF2A also caused an enlarged heart and abnormali- 
ties of notochord and tail in Xenopus embryos. These 
findings suggest that both XCsx2 and XMEF2A transcrip- 
tion factors have an important role in regulating the ex- 
pression of the XMHCc~ gene and the morphogenesis of 
heart tissue in Xenopus development. 
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Introduction 
Since the discovery of the homeobox motif in genes of 
the Drosophila homeotic (HOM-C) complex (McGinnis 
et al. 1984; Scott and Weiner 1984), homeobox genes 
have been known to play important roles in Drosophila 
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segmentation and the elaboration of pattern formation 
during embryogenesis. Recently, a homeobox gene, tin- 
man, has been reported which encodes a protein required 
for visceral and cardiac mesoderm formation in Dro- 
sophila (Azpiazu and Frasch 1993; Bodmer 1993). Tin- 
man mutants have no visceral or cardiac mesoderm, re- 
sulting in an absence of the dorsal vessel, or "heart". 
These results provide evidence that tinman plays a cru- 
cial role in cardiac muscle myogenesis. Homeobox genes 
are transcription factors which bind to target genes to 
modulate cell determination and differentiation processes 
in embryonic development (reviewed by Scott 1994). It 
is clearly important to find whether they produce their 
effects on morphogenesis by regulating target genes that 
are at the upper end of a cascade during embryonic de- 
velopment. 
Analysis of Drosophila homeobox genes and discov- 
ery of their vertebrate counterparts has provided a useful 
paradigm for studying the roles of these genes in embry- 
ogenesis. Vertebrate homologue of the tinman gene of 
Drosophila, mouse Csx~kx-2.5 and Xenopus 
XCsx2/XNkx-2.5 genes have been found to be expressed 
during cardiac muscle myogenesis (Komuro and Izumo 
1993; Lints et al. 1993; Tonissen et al. 1994; Komuro et 
al., in preparation). 
In vertebrate skeletal muscle myogenesis, the MyoD 
family of transcription factors act as determination fac- 
tors and regulate the expression of some muscle-specific 
genes. However, in cardiac muscle myogenesis, very lit- 
tle is known about the determination functions of cardi- 
ac-specific transcription factors. Recently, the myocyte 
enhancer factor 2 (MEF2) transcription factor family has 
been found in skeletal and cardiac myocytes. There are 
four MEF2 genes, MEF2A, MEF2B, MEF2C and 
MEF2D, which have been isolated from mice (Martin et 
al. 1993, 1994), and homologues in humans (Pollock and 
Treisman 1991; Yu et al. 1992; Breitbart et al. 1993; Lei- 
fer et al. 1993; McDermott et al. 1993) and frogs (Cham- 
bers et al. 1992). MEF2 gene transcripts are detected at 
high levels in myogenic cells of the myotome and the 
embryonic heart in mice (Edmondson et al. 1994). The 
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expression of  the MEF2 gene family in the early heart 
and somites suggests that these transcription factors may  
play some important  roles in activation of  muscle-specif-  
ic transcription in both cardiac and skeletal muscle and 
raises the possibility that MEF2 genes could account  for 
the overlapping pattern of  gene expression in these two 
muscle  cell types. 
Little is currently known about the relationships 
among XCsx2, XMEF2A, and their target or regulatory 
genes in muscle  myogenesis .  We have been interested in 
investigating the regulatory functions o f  these two trans- 
ciption factors using the Xenopus myosin  heavy-chain  al- 
pha (XMHCoO gene as a marker  for cardiac muscle de- 
velopment.  As the XMHC~z gene transcript is highly en- 
riched in adult heart R N A  and embryonical ly  is ex- 
pressed exclusively in heart tissue, it provides a tissue- 
specific marker  for cardiac muscle differentiation during 
early embryogenesis  (Logan and Mohun  1993). By  use 
of  microinject ion o f  synthetic m R N A s  into developing 
embryos,  we demonstrate  that ectopic expression of  
XCsx2 and/or XMEF2A can induce precocious expres- 
sion o f  the XMHCo~ gene f rom stage 14 or 12 in whole  
embryos  but not in animal pole explants when either or 
both m R N A s  are injected into early Xenopus embryos.  
The overexpression of  XCsx2 or XMEF2 also results in 
an enlarged heart and abnormalit ies o f  notochord and tail 
in injected embryos.  
Materials and methods 
Dissection of embryos and explant culture 
When embryos developed to midblastula stage (stage 8) (Ni- 
euwkoop and Faber 1956), animal poles of the embryos were cut 
off from the whole embryos in 1 x MMR solution supplemented 
with 3% Ficoll 400 and sodium penicillin and streptomycin sul- 
fate, each at 10 mg/ml. The animal pole explants were left in the 
same solution for 30 rain and then transferred into a culture solu- 
tion (0.1 x MMR solution supplemented with some growth factors 
according to the different experimental purposes). Basic fibroblast 
growth factor (bFGF; Gibco BRL) was used at a concentration of 
200 ng/ml and transforming growth factor-fl (TGF-fl; Gibco BRL) 
at 20 ng/ml in phosphate-buffered saline (PBS) with 0.1% bovine 
serum albumin (BSA). Activin A was used at 50 U/ml. After the 
explants were cultured for 36 h (stage 35), they were collected for 
assay of XMHCo~ transcripts. 
RNA extraction and RT-PCR assays 
Ten animal pole explants or eight embryos were extracted with 
RNA extraction buffer (0.1 M Tris, 0.5% SDS, 0.1 M NaC1, 0.01 
M EDTA and 150 gg/ml Proteinase K). The RNA samples were 
treated with RQ1 RNase-Free DNase (Promega), and cDNAs were 
synthesized with SuperScript II RNaes H-reverse transcriptase 
(RT; Gibco BRL) at 45 ° C for 2 h with RNA extracted from ten 
animal pole explants or eight embryos. A tenth part volume of the 
transcription reaction solution was used for a polymerase chain re- 
action (PCR) with Vent DNA polymerase (New England Biolabs). 
The sequences of the primers used were: XMHCoc: 5' primer, CA 
CGA GCT GGA TGA GGC TG; 3' primer, AG TGC TGA ATT T 
AA TGG TC. Elongation factor-la (EF-la): 5' primer, CCT GAA 
TCA CCC AGG CCA GAT TGG TG; 3' primer, GAG GGT AGT 
CTG AGA AGC TCT CCA CG. The conditions for PCR were: 
94 ° C for 3 rain, annealing at 55 ° C for 1.5 rain and elongation at 
72 ° C for l min, followed by 24 cycles at 94 ° C for 1 min, at 55 ° 
C for 1.5 min and at 72 ° C for 1 min. 
Plasmid construction and in vitro transcription 
The full-length XCsx2/XNkx-2.5 (Tonissen etal. 1994) or 
XMEF2A/SL2 (Chambers et al. 1994) cDNA fragment was insert- 
ed into EcoRI and Xhol sites of the pSP64RI vector and the DNA 
sequence confirmed by sequence analyses. To generate sense 
p64T-XCsx2 or p64T-XMEF2A transcripts, the p64T-XCsx2 or 
p64T-XMEF2A plasmid was digested with SacI and transcribed 
with SP6 RNA polymerase (Krieg and Melton 1984). For making 
antisense transcripts, the SK-XCsx2 or SK-XMEF2A plasmid 
was digested with EcoRI, and SK-XMHC~ with PstI, and tran- 
scribed with T7 RNA polymerase. The qualities of the synthetic 
mRNAs were assessed by gel electrophoresis. 
Microinjection of embryos 
Specimens of Xenopus laevis were purchased from Xenopus I. 
Ovulation was induced by injecting 300 U/each of human chorion- 
ic gonadotropin (HCG) (Fu etal. 1989). Fertilized eggs were de- 
jellied with 2% cysteine-HC1 (pH 7.8) immediately following cor- 
tical rotation. For each microinjection experiment, 200 fertilized 
embryos were injected with 2 ng/10 nl of XCsx2 or XMEF2A 
mRNA at the two-cell stage in 1 x MMR solution (Peng 1991) 
supplemented with 3% Ficoll 400 and sodium penicillin and strep- 
tomycin sulfate, each at 10 mg/ml. Control injections were per- 
formed with fl-galactosidase mRNA. After several cell cycles 
(about 3-4 h), the embryos were transferred to 0.1 x MMR solu- 
tion for development. The developmental stages of injected em- 
bryos were determined by comparison with non-injected embryos 
(Nieuwkoop and Faber 1956). Each experiment was performed at 
least three times. 
In situ hybridization and histology 
Whole-mount in situ hybridization was performed according to 
Harland (1991). Embryos for sectioning were fixed with 4% para- 
formaldehyde at 4°C overnight. Embryo sections were stained 
with eosin (Kelly et al. 1991). 
Results and discussion 
Induct ion of  early expression of  the XMHCa gene 
in the whole  Xenopus embryo by overexpression 
of  XCsx2 or XMEF2A 
In mouse  embryogenesis ,  Csx and MEF2 genes begin to 
be expressed in cardiac primordia around 7.5 days post 
coitum, at a stage when the primordial  heart is s imply a 
region of  thickened splanchnic mesoderm. Csx and 
MEF2 genes are the earliest known markers o f  vertebrate 
heart development,  and these transcription factors may  
play important  roles for cardiac muscle differentiation 
(Bodmer  1995). Al though it is still not known whether 
there is a relationship between Csx and MEF2 genes, it is 
possible that these transcription factors have some same 
or similar functions in early muscle cell differentiation. 
In this paper, we have used XMHCa as a marker  gene to 
investigate interactions between XCsx2 or XMEF2A and 
the XMHCc~ gene in developing Xenopus embryos.  
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Fig. 1 RT-PCR assays demonstrate different expression patterns 
of the XMHCo~ gene in normal and injected Xenopus embryos dur- 
ing development. A The expression of the XMHCo~ gene was ex- 
amined at different developmental stages of non-injected normal 
embryos: stage 8 (midblastula), stage 12 (late gastrula), stage 14 
(neural plate), stage 18 (neural groove), stage 26 (tailbud), stage 
35 (late tailbud), and stage 42 (tadpole). XMHCo~ gene expression 
was detected from stage 26 onward. B After injection of XCsx2 
mRNA, expression of the XMHCo~ gene was detected from stage 
14. C As with the XCsx2 mRNA injection experiment, injecting 
XMEF2A mRNA induced expression of the XMHCo~ gene from 
stage 14 in whole embryos. D Yet earlier expression of the 
XMHCa gene, from stage 12, was detected after co-injection of 
XCsx2 and XMEF2A mRNAs. E Expression of the EF-lc~ gene as 
an internal control for amounts of RNA in D for different stages of 
Xenopus embryos. 
In order to investigate the relationship between XCsx2 
or XMEF2A transcription factors and contractile muscle 
gene expression, we microinjected mRNAs for the tran- 
scription factors into two-cell stage Xenopus embryos 
and examined the expression of the XMHCa gene during 
embryonic development by RT-PCR assays. In non-in- 
jected embryos, the XMHCa gene is first expressed at 
the tailbud stage (stage 26) (Logan and Mohun 1993; and 
Fig. 1A). However, when either XCsx2 or XMEF2A 
mRNA was injected into two-cell stage Xenopus embry- 
os, the expression of the XMHCo~ gene was induced from 
stage 14 in whole embryos (Fig. 1B, C). As injection of 
either XCsx2 or XMEF2A mRNA induced the early ex- 
pression of XMHCa gene in the whole embryo, we want- 
ed to examine the effect of co-injection of both XCsx2 
and XMEF2A mRNAs into two-cell stage Xenopus em- 
bryos. Expression of XMHCo~ gene after co-injection 
was observed from stage 12 rather than from stage 14 in 
the whole embryo (Fig. 1D). However, expression of the 
XMHCo~ gene after co-injection was lower than injection 
of either XCsx2 or XMEF2A mRNA alone. This may re- 
flect a regulatory interaction between XCsx2 and 
XMEF2A affecting XMHCo~ gene regulation. The RT- 
PCR signal obtained for XMHCo~ gene expression (Fig. 
1D) was normal, evaluated from the signal obtained for 
elongation factor-lo~ (EF-la; Fig. 1E). 
These results from ectopic overexpression of XCsx2 
and XMEF2A indicated that both can induce the preco- 
cious expression of the XMHCa gene in Xenopus em- 
bryo development, suggesting that these transcription 
factors may play an important role in cardiac muscle 
myogenesis. 
Animal cap experiments were also performed. Fol- 
lowing injection of XCsx2 or XMEF2A mRNA into two- 
cell stage embryos, animal poles were explanted at stage 
8 and cultured until stage 35. No expression of the 
XMHCo~ gene was detected in animal pole explants with 
various injection doses of XCsx2 or XMEF2A mRNA, 
co-injection of XCsx2 and XMEF2A mRNAs, or injec- 
tion of these mRNAs with combinations of treatment 
with different growth factors, including bFGF, TGF-fl 
and Activin A (data not shown). The inability of injected 
XMEF2A mRNA to induce expression of XMHCa gene 
in animal pole explants confirms the findings of previous 
investigators (Chambers et al. 1994). These results sug- 
gest that XCsx2 and XMEF2A regulate expression of 
XMHCa gene with unknown cofactor(s) in mesoderm or 
endoderm which are not present in animal caps explant- 
ed at the midblastula stage (stage 8). 
Enlarged hearts and abnormalities of notochord 
and tail in embryos with ectopic overexpression 
of XCsx2 or XMEF2A 
After embryos were injected with XCsx2 or XMEF2A 
mRNA, they began to develop abnormally at late gastru- 
lation. At stage 12, the embryos injected with XCsx2 or 
XMEF2A mRNA had larger yolk plugs than control em- 
bryos. From stage 14, the neural fold in experimental 
embryos did not close, exposing inner dorsal cells until 
late stages. Whole-mount in situ hybridization analysis 
was used to examine XMHCo~ transcripts in late tailbud 
stage embryos. Injection of XMEF2A mRNA resulted in 
more severe abnormalities than injection of XCsx2 mR- 
NA, as indicated by the length of the embryonic body; 
the embryos developed an abnormal notochord and tail 
phenotype with enlarged hearts (Fig. 2C E). These fea- 
tures were not observed in control embryos which had 
been injected with fl-galactosidase mRNA (Fig. 2A). 
Among surviving embryos, about 70% injected with 
XMEF2A mRNA or co-injected with XCsx2 and 
XMEF2A mRNAs, and about 50% injected with XCsx2 
mRNA, had the abnormal phenotype (Table 1). 
In order to examine the effect on embryos injected 
with XCsx2 or XMEF2A mRNA in more detail, whole- 
mount stained embryos were longitudinally sectioned. 
The enlarged heart observed in the XMEF2A mRNA-in- 
jected embryos was evident (Fig. 2D) on comparison 
with the heart in the fl-galactosidase mRNA-injected em- 
bryos (Fig. 2B). The findings were the same in embryos 
which were injected with XCsx2 mRNA or co-injected 
with XCsx2 and XMEF2A mRNAs (data not shown). 
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Fig. 2 Whole-mount in sire hybridization analyses of XMHCo~ 
gene expression at stage 35 in injected embryos. A The transcripts 
of the XMHCo~ gene were examined in a fl-galactosidase mRNA-in- 
jected embryo; the arrowhead indicates the heart. B Expression of 
the XMHC~z gene was observed in myocardium in longitudinal sec- 
tion through heart. Vt indicates the ventricle and At the atrium in the 
fl-galactosidase mRNA-injected Xenopus embryo. C XMHCa gene 
transcripts in an embryo that was injected with XMEF2A mRNA 
were examined at stage 35; the arrowhead indicates the enlarged 
heart. D Expression of the XMHCa gene in the myocardium of the 
embryo that was injected with XMEF2A mRNA is shown in longitu- 
dinal section through the heart. The ventricle is enlarged. E In an 
embryo injected with XCsx2 mRNA, an enlarged heart (arrowhead) 
is evidenced by whole-mount in situ hybridization. Note that the 
embryo body is a little longer than that shown in C and shorter than 
that in the fl-galactosidase mRNA-injected embryo A 
Table 1 The number of embryos used in experiments for injection 
of different mRNAs. Embryos were injected with 5 ng of mRNA 
at the two-cell stage and raised to stage 35 (late tailbud) for check- 
ing the phenotype. The abnormal phenotype includes a split noto- 
chord and neural tube and a truncated tail. The values are averages 
from three independent experiments 
mRNA injected No. of embryos Phenotype normal (%) Phenotype abnormal (%) Died (%) 
fl-aal 200 187 (93.5) 2 a (1.0) 11 (5.5) 
XCsx2 200 63 (31.5) 68 (34.0) 69 (34.5) 
XMEF2A 200 36 (18.0) 94 (47.0) 70 (35.0) 
XCsx2+XMEF2A 200 45 (22.5) 89 (44.5) 66 (33.0) 
a Nonspecific sacculated abdomen 
The abnormal  phenotype  caused by overexpression of  
XCsx2 and/or X M E F 2 A  was observed f rom stage 12. At 
this stage in normal  embryo development,  mesodermal  
and endodermal  cells are migrat ing toward the animal 
pole, involution on the dorsal side has advanced, and a 
small yolk plug is present  on the embryos.  However,  in 
experimental embryos,  larger yolk plugs were observed 
at stage 12, possibly resulting in a split notochord.  It 
may  be that overexpression of  XCsx2 or XMEF2A retards 
the movements  o f  mesodermal  and endodermal  cells dur- 
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ing the cellular involution which occurs during gastrula- 
tion. Perhaps as a result of the abnormal movements, clo- 
sure of the neural folds was delayed during neurulae 
stages, which could account for the truncated tail. Re- 
cently, it has been reported that treatment of cleavage 
stage embryos with lithium increases the heart tissue but 
interferes with migration of the primordia to the ventral 
midline for fusing to form the mature heart, which does 
not appear to be enlarged (Drysdale et al. 1994). In view 
of our finding that ectopic overexpression of XCsx2 or 
XMEF2A resulted in enlarged hearts, the mechanism 
probably differs from that of lithium treatment. Ludolph 
etal. (1994) recently reported that overexpression of 
XMyoD and XMyf5 causes the formation of enlarged 
myotomes through recruitment of cells of nonsomitic 
lineage rather than b y  an increase in muscle precursor 
cell division. It will be of interest to investigate whether 
a similar mechanism is operative in the heart enlarge- 
ment found in our study. 
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